Thursday, March 30, 2017

BioTek at AACR 2017

The American Association for Cancer Research (AACR) will hold its annual meeting next week from April 1-5 in Washington D.C. The meeting will celebrate an important anniversary and marks a homecoming of sorts as the association was founded 110 years ago in Washington D.C. This conference represents the largest gathering of cancer researchers and clinicians from around the world, as each year more than 18,000 people attend to learn about new advances within oncology.

One area promising to receive a great deal of interest this year is the field of immuno-oncology. Here the goal is to stimulate a patient’s own immune system to fight the specific cancer. Therefore, new drugs, or immunotherapies, are developed to target not the individual cancer cells, but particular cells of the immune system, such as natural killer (NK) or cytotoxic T lymphocytes (CTLs). BioTek will present an Exhibitor Spotlight Tutorial in cooperation with Lonza and Greiner Bio-One entitled “Demonstration of High Throughput, Image-Based 2D and 3D Natural Killer Cell Mediated Cytotoxicity Assays” to illustrate how in vitro immunotherapy optimization experiments can be performed in a walk-away manner and analyzed using highly sensitive cellular imaging. The tutorial will take place on Tuesday, April 4th from 4-5:00pm in Spotlight Theater B. We invite you to attend the talk and to stop by our booth (1857) to learn about all the 2D and 3D oncology applications optimized using BioTek’s instrumentation.

3D HCT116 tumoroid exhibiting apoptosis and necrosis following NK cell exposure.
3D HCT116 tumoroid exhibiting apoptosis and necrosis following NK cell exposure.
 
By: BioTek Instruments, Brad Larson, Principal Scientist

No comments:

Post a Comment